William H. Rastetter, Director at Regulus Therapeutics Inc. (RGLS), bought 100,000 shares at $10.13 ($1.0M) on 2015-07-20, disclosed to the SEC on 2015-07-21.
Open-market purchase of $1.0M RGLS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.13 | 38,765 | $393K | 38.6% |
| 2 | $10.19 | 61,235 | $624K | 61.4% |
| Total | $10.17 avg | 100,000 | $1.0M | 100% |
| Filing → |
| NBIX | SELL | 2024-08-16 | $4.2M | — | Filing → |
| NBIX | SELL | 2024-01-04 | $2.9M | — | Filing → |
| NBIX | SELL | 2023-05-03 | $872K | — | Filing → |